Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
somatropin (Gylden Pharma)
- Development stage
- Unknown
- Lead developer
- Gylden Pharma
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Transdermal
01
Overview
Somatropin is a recombinant human growth hormone (rhGH) being developed by Gylden Pharma using a proprietary transdermal microneedle patch delivery system. This formulation aims to improve patient adherence and convenience by replacing daily subcutaneous injections with a minimally invasive patch. Somatropin acts as an agonist at the growth hormone receptor (GHR), which induces the synthesis and release of insulin-like growth factor 1 (IGF-1) and promotes linear growth, protein deposition, and lipolysis. Gylden Pharma's somatropin patch is currently in Phase 1 clinical development for the treatment of growth hormone deficiency (GHD), various growth disorders, and potentially diabetes-related indications, representing a significant advancement in the delivery of large-molecule biologics.
- Other names
- Recombinant human growth hormonehGH
02
Targets
GHR (Growth hormone receptor)
Beyond the preview
Go deeper on somatropin (Gylden Pharma).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on somatropin (Gylden Pharma).